Skip to main content
Premium Trial:

Request an Annual Quote

Air Force Cancels ABI Biosecurity Contract

NEW YORK (GenomeWeb News) - The US Department of Defense has terminated a pathogen-identification technology contract with Applied Biosystems because the company and the US Air Force could not agree on the best route for commercializing the product, ABI said Friday. 
 
The DOD awarded ABI a $24.5 million contract last August to develop a prototype system that would identify infectious diseases for epidemiological and biosecurity purposes.
 
ABI said on Friday that it had successfully completed all technical milestones for the contract, but that it was unable to agree with the USAF on “an approach for further development and commercialization of an instrument” based on an ABI prototype.
 
ABI said it anticipates “no material financial impact” from the cancellation of the contract and expects to continue developing pathogen-detection technology for biosecurity applications.
The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.